Related Experiment Video
Updated: Sep 5, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Application of Mediterranean Diet in Cardiovascular Diseases and Type 2 Diabetes Mellitus: Motivations and Challenges
Najwa Salim AlAufi1, Yoke Mun Chan1, Mostafa I Waly2
1Department of Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Seri Kembangan 43400, Selangor, Malaysia.
Insights
The Mediterranean diet (MedDiet) shows strong evidence for improving cardiovascular disease (CVD) and Type 2 diabetes mellitus (T2DM) risk factors. Despite challenges in application and research, MedDiet offers a practical approach to prevention and treatment.
Area of Science:
- Nutrition Science
- Cardiology
- Endocrinology
Background:
- Cardiovascular disease (CVD) and Type 2 diabetes mellitus (T2DM) are leading causes of premature death.
- The Mediterranean diet (MedDiet) is recognized for its potential protective effects against CVD and T2DM.
- Despite evidence, challenges in applying and researching the MedDiet persist.
Purpose of the Study:
- To explore the motivations behind adopting the MedDiet.
- To identify the challenges associated with MedDiet implementation in patients with CVD and T2DM.
- To review the existing literature on MedDiet's role in managing CVD and T2DM.
Main Methods:
- An extensive electronic literature search was performed across major databases (PubMed, ScienceDirect, Scopus, Web of Science).
- The search focused on studies published up to December 2021 concerning MedDiet in CVD and T2DM patients.
- A rigorous selection process resulted in 108 eligible studies from an initial 1536.
Main Results:
- Motivations for MedDiet include its holistic dietary pattern, health benefits, and unique characteristics.
- Key challenges involve the lack of a universal MedDiet definition and scoring, and the impact of nutritional transition towards Westernized diets.
- Research challenges include inconsistent findings, limited evidence, and difficulties in generalizing results.
Conclusions:
- Consistent evidence supports MedDiet's inverse association with CVD risk factors and direct impact on glycemic control.
- MedDiet is a subject of active research despite existing implementation and study challenges.
- MedDiet presents a potentially revolutionary, practical, and non-invasive strategy for preventing and treating CVD and T2DM.
Objective:
Cardiovascular disease (CVD) is the leading cause of disability and death in many countries. Together with CVD, Type 2 diabetes mellitus (T2DM) accounts for more than 80% of all premature non-communicable disease deaths. The protective effect of the Mediterranean diet (MedDiet) on CVD and its risk factors, including T2DM, has been a constant topic of interest. Notwithstanding, despite the large body of evidence, scientists are concerned about the challenges and difficulties of the application of MedDiet. This review aims to explore the motivations and challenges for using MedDiet in patients with CVD and T2DM.
Design:
An electronic search was conducted for articles about MedDiet published in PubMed, ScienceDirect, Scopus, and Web of Science up to December 2021, particularly on CVD and T2DM patients. From a total of 1536 studies, the final eligible set of 108 studies was selected. Study selection involved three iterations of filtering.
Results:
Motivation to apply MedDiet was driven by the importance of studying the entire food pattern rather than just one nutrient, the health benefits, and the distinct characteristics of MedDiet. Challenges of the application of MedDiet include lacking universal definition and scoring of MedDiet. Influences of nutritional transition that promote shifting of traditional diets to Westernized diets further complicate the adherence of MedDiet. The challenges also cover the research aspects, including ambiguous and inconsistent findings, the inexistence of positive results, limited evidence, and generalization in previous studies. The review revealed that most of the studies recommended that future studies are needed in terms of health benefits, describing the potential benefits of MedDiet, identifying the barriers, and mainly discussing the effect of MedDiet in different populations.
Conclusions:
In general, there is consistent and strong evidence that MedDiet is associated inversely with CVD risk factors and directly with glycemic control. MedDiet is the subject of active and diverse research despite the existing challenges. This review informs the health benefits conferred by this centuries-old dietary pattern and highlights MedDiet could possibly be revolutionary, practical, and non-invasive approach for the prevention and treatment CVD and T2DM.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Diabetes Mellitus: Type 2 and Gestational
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

